The newspaper El Correo has highlighted the work of
Lourdes Basabe and the Microfluidics Cluster UPV/EHU in a major
feature devoted to cancer research in Álava.
On Sunday, 27 September, El Correo dedicated its front page and a
two-page feature entitled “La vanguardia alavesa contra el cáncer” to
research groups in Álava working on new approaches to understand,
diagnose and treat different types of cancer.
Among the researchers featured is Lourdes Basabe, Ikerbasque Research
Professor and Director of the Microfluidics Cluster UPV/EHU, whose
work focuses on the development and application of microfluidic
technologies to study biological processes at the cellular scale.
In the article, Basabe explains how microfluidic devices —typically
fabricated using materials such as glass or polymers and designed to
manipulate very small volumes of liquid— make it possible to reproduce
and analyse biological processes under highly controlled conditions.
These technologies, which are already present in applications ranging
from diagnostic tests to glucose monitoring systems, offer important
opportunities for biomedical research.
One of the research lines highlighted by El Correo is the work
carried out together with researcher Edurne Alonso, based on the
integration of sensors around cells in order to precisely determine
which proteins they secrete when exposed to different stimuli. This
approach is being applied to the study of different types of
testicular germ cell tumours, with the aim of identifying their
molecular characteristics, distinguishing between tumour subtypes and
helping to understand why some variants show more aggressive behaviour
than others.
Microfluidics therefore provides a powerful tool to study cellular
behaviour in highly controlled and reproducible environments, while
progressively enabling the development of models that can mimic key
functions of tissues and organs. In this context, Basabe also refers
to the recent award of a European project focused on the development
of a “digital twin”, where these technologies may contribute to
reproducing biological functions and studying cellular responses in
greater detail, with potential applications in therapy optimisation
and disease modelling.
The feature places this research within the wider biomedical research
ecosystem of Álava, alongside work on early diagnosis, immunotherapy,
genetics, microbiome research, artificial tissue models,
ultrasound-based approaches and new therapeutic strategies.
Basabe-Desmonts also stresses the high scientific quality of the
research currently being carried out in the region, while pointing to
the need for sustained institutional and financial support to maximise
its impact and ensure the long-term development of local research talent.
The presence of the Microfluidics Cluster UPV/EHU in this special
feature by El Correo highlights the growing role of microfluidics and
Lab-on-a-Chip technologies in biomedical research, both for advancing
fundamental understanding of disease and for developing new diagnostic
tools and therapeutic strategies.
Source: El Correo, Álava edition, Sunday 27 September 2026, feature
article “La vanguardia alavesa contra el cáncer”.